Serious fungal infections are rising due to the increased use of immunosuppressive agents (either employed to sustain organ transplants or as the result of cancer therapy). Membrane sterol and the sterol biosynthetic pathway have long been target sites for antifungal drugs. Two of the most widely used antifungal classes, the polyenes (amphotericin B) target plasma membrane-bound sterols and the azoles (fluconazole, and itraconazole) target the cytochrome P450-mediated step, lanosterol C-14 demethylation. Saccharomyces cerevisiae contains the best characterized sterol pathway at the genetic and molecular levels and is an excellent model system to study the topographical organization of sterol enzymes and the interactions between these enzymes within one or more sterol complexes. The post-squalene pathway leading to ergosterol in fungi or cholesterol in animal cells share eleven enzymatic reactions in addition to a scaffold protein required for efficient C-4 demethylation. In the post-squalene pathway only two enzymes in the cholesterol pathway and three in the ergosterol pathway account for the structural differences between these molecules. One goal of this proposal is to co-immunoprecipitate the sterol biosynthetic enzymes in order to determine whether there is a single enzymatic complex or several interacting complexes leading to end-product sterol. Specific pair wise enzymatic interactions will be evaluated using a membrane two-hybrid system. In addition interactions between sterol biosynthetic enzymes and sterol esterification enzymes will also be studied. A second major goal of this proposal is to investigate how loss of the ERG27 gene product leads to loss of the upstream enzymatic reaction, the oxidosqualene cyclase (Erg7p). This interaction will be studied at the transcriptional and post-translational levels. A number of transcriptional activators and repressors that affect several genes in the sterol pathway will be studied. Among these are the UPC2 and ECM22, YER064c and MOT3. A screen for novel transcriptional regulators of the C-4 demethylation genes will also be undertaken. Finally, we will complete our analysis of the ERG9 promoter which encodes the squalene synthase, the first enzyme in the mevalonate-sterol pathway dedicated to sterol synthesis. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM062104-10
Application #
6772271
Study Section
Microbial Physiology and Genetics Subcommittee 2 (MBC)
Program Officer
Anderson, James J
Project Start
1995-06-01
Project End
2008-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
10
Fiscal Year
2004
Total Cost
$219,501
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Munkacsi, Andrew B; Chen, Fannie W; Brinkman, Matthew A et al. (2011) An ""exacerbate-reverse"" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease. J Biol Chem 286:23842-51
Taramino, Silvia; Teske, Brian; Oliaro-Bosso, Simonetta et al. (2010) Divergent interactions involving the oxidosqualene cyclase and the steroid-3-ketoreductase in the sterol biosynthetic pathway of mammals and yeasts. Biochim Biophys Acta 1801:1232-7
Taramino, S; Valachovic, M; Oliaro-Bosso, S et al. (2010) Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast. Biochim Biophys Acta 1801:156-62
Willger, Sven D; Puttikamonkul, Srisombat; Kim, Kwang-Hyung et al. (2008) A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog 4:e1000200
Teske, B; Taramino, S; Bhuiyan, M S A et al. (2008) Genetic analyses involving interactions between the ergosterol biosynthetic enzymes, lanosterol synthase (Erg7p) and 3-ketoreductase (Erg27p), in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1781:359-66
Shah Alam Bhuiyan, M; Eckstein, James; Barbuch, Robert et al. (2007) Synthetically lethal interactions involving loss of the yeast ERG24: the sterol C-14 reductase gene. Lipids 42:69-76
Hughes, Adam L; Powell, David W; Bard, Martin et al. (2007) Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 5:143-9
Loertscher, Jennifer; Larson, Lynnelle L; Matson, Clinton K et al. (2006) Endoplasmic reticulum-associated degradation is required for cold adaptation and regulation of sterol biosynthesis in the yeast Saccharomyces cerevisiae. Eukaryot Cell 5:712-22
Valachovic, Martin; Bareither, Bart M; Shah Alam Bhuiyan, M et al. (2006) Cumulative mutations affecting sterol biosynthesis in the yeast Saccharomyces cerevisiae result in synthetic lethality that is suppressed by alterations in sphingolipid profiles. Genetics 173:1893-908
Rahier, Alain; Darnet, Sylvain; Bouvier, Florence et al. (2006) Molecular and enzymatic characterizations of novel bifunctional 3beta-hydroxysteroid dehydrogenases/C-4 decarboxylases from Arabidopsis thaliana. J Biol Chem 281:27264-77

Showing the most recent 10 out of 28 publications